english.prescrire.org > Spotlight > 100 most recent > Anticoagulants and heavy menstrual bleeding

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

Anticoagulants and heavy menstrual bleeding

 Adverse Effects  According to 2 cohort studies published in 2022 and 2023, 2 out of 3 women under 50 years of age on anticoagulant treatment for venous thromboembolism or pulmonary embolism have troublesome heavy menstrual bleeding, with sometimes major consequences for their everyday lives. In this situation, the insertion of an intrauterine device containing levonorgestrel usually reduces the volume of menstrual blood loss, with largely acceptable adverse effects.
Full article available for download by subscribers

 ©Prescrire 1 March 2025

Source: "Anticoagulants and heavy menstrual bleeding: impact on patients’ lives" Prescrire Int 2025; 34 (268): 76-78. Subscribers only.

Filet

Enjoy full access to Prescrire International, and support independent information

 
Share
Share on Facebook  
 
 
See also:
 
"Deep vein thrombosis
and pulmonary embolism.
Treatment with warfarin,
LMWH or apixaban,
depending on the situation"
Prescrire Int 2021;
30 (223): 49-50.
Subscribers only